⌘K

Home/Filings/4/0001181431-13-016067

4//SEC Filing

Bender James G. 4

Accession 0001181431-13-016067

CIK 0000822411other

View on SEC.gov Company Profile

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 5:35 PM ET

Size

5.4 KB

Accession

0001181431-13-016067

Insider Transaction Report

Form 4

Period: 2013-03-07

ImmunoCellular Therapeutics, Ltd.IMUC

Bender James G.

VP, Product Development & Mfg.

Transactions

Award
Stock Option (right to buy)
2013-03-07−80,000→ 80,000 total
Exercise: $2.72Exp: 2020-02-29→ Common Stock (80,000 underlying)

Footnotes (1)

[F1]The option vests in equal monthly installments over four years beginning March 1, 2013.

Documents

1 file

4
rrd373035.xmlPrimary
PRIMARY DOCUMENT

Issuer

ImmunoCellular Therapeutics, Ltd.

CIK 0000822411

Entity typeother

Related Parties

1

filerCIK 0001550455

Filing Metadata

Form type: 4
Filed: Mar 10, 8:00 PM ET
Accepted: Mar 11, 5:35 PM ET
Size: 5.4 KB

View on SEC.gov